Herb–drug interaction study of Yiqi Fumai lyophilized injection (YQFM) on pharmacokinetics of aspirin, nifedipine, and clopidogrel in rats
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.6018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Dayong Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, North China University of Science and Technology, Tangshan, China. Hauptthemen laut MEDLINE: Clopidogrel, Drugs, Chinese Herbal, Aspirin, Herb-Drug Interactions. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Natural Science Foundation of Hebei Province, Medical Science Research Project of Hebei Province, National Project for Standardization of Chinese Materia Medica.
Abstract (Originalsprache)
Yiqi Fumai lyophilized injection (YQFM), a compound traditional Chinese medicine prescription derived from “Sheng Mai Powder,” is approved for the treatment of cardiovascular diseases. YQFM is usually prescribed in combination with some Western medicines to treat patients, such as aspirin, nifedipine, and clopidogrel. However, the herb–drug interactions (HDIs) of YQFM are still unclear. We determined the effect of YQFM on drug metabolism‐related CYP450 enzymes by in vitro assays. And the effects of YQFM on the pharmacokinetics of aspirin, nifedipine, or clopidogrel were analyzed in rats, as well as the effect of YQFM on the prothrombin time of aspirin or clopidogrel, to evaluate the safety and efficacy of co‐administration. Our study indicated that the clinical dose of YQFM did not significantly influence the relevant CYP450 isoenzymes. Besides, YQFM had no effect on the pharmacokinetics of aspirin, nifedipine, or clopidogrel single and multiple administrations in rats. In pharmacodynamics study, YQFM also had no impact on prothrombin time of aspirin or clopidogrel. Based on the results of pharmacogenomics, pharmacokinetics, and pharmacodynamics, the HDIs of YQFM have a good safety profile, and the combination with the above three drugs might have synergistic effects due to the different efficacy of YQFM‐quality markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, North China University of Science and Technology, Tangshan, China.
- School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, China.
- State Key Laboratory of Core Technology in Innovation Chinese Medicine, Tasly Pharmaceutical Group Co., Ltd., Tianjin, China.
- Tasly Academy, Tasly Holding Group Co., Ltd., Tianjin, China.
- Tianjin Tasly Pride Pharmaceutical Co., Ltd., Tianjin, China.
ORCID-Profile: Dayong Zheng
Förderung
- Natural Science Foundation of Hebei Province
- Medical Science Research Project of Hebei Province
- National Project for Standardization of Chinese Materia Medica
Zitieren
APA
Zheng, D., Bai, J., Wang, Y., Li, X., Chu, Y., Li, D., Ju, A., Xie, Y., & Li, W. (2024). Herb–drug interaction study of Yiqi Fumai lyophilized injection (YQFM) on pharmacokinetics of aspirin, nifedipine, and clopidogrel in rats. Biomedical Chromatography. https://doi.org/10.1002/bmc.6018
Vancouver
Zheng D, Bai J, Wang Y, Li X, Chu Y, Li D, et al. Herb–drug interaction study of Yiqi Fumai lyophilized injection (YQFM) on pharmacokinetics of aspirin, nifedipine, and clopidogrel in rats. Biomedical Chromatography. 2024. doi:10.1002/bmc.6018
BibTeX
@article{Zheng2024,
author = {Zheng, Dayong and Bai, Jiaxuan and Wang, Yiran and Li, Xiaoyang and Chu, Yang and Li, Dekun and Ju, Aichun and Xie, Yuesheng and Li, Wei},
title = {Herb–drug interaction study of Yiqi Fumai lyophilized injection (YQFM) on pharmacokinetics of aspirin, nifedipine, and clopidogrel in rats},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.6018}
}
EUVIMED